UK markets open in 23 minutes
NIKKEI 225
37,934.76 +306.28 (+0.81%) HANG SENG
17,735.11 +450.57 (+2.61%) CRUDE OIL
84.00 +0.43 (+0.51%) GOLD FUTURES
2,351.20 +8.70 (+0.37%) DOW
38,085.80 -375.12 (-0.98%) Bitcoin GBP
51,486.43 +30.31 (+0.06%)
IDEAYA Biosciences, Inc. (IDYA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.89B |
| Enterprise value | 2.37B |
| Trailing P/E | N/A |
| Forward P/E | 4.65 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 94.99 |
| Price/book (mrq) | 4.65 |
| Enterprise value/revenue | 101.14 |
| Enterprise value/EBITDA | -18.13 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.80 |
| 52-week change 3 | 111.50% |
| S&P500 52-week change 3 | 21.08% |
| 52-week high 3 | 47.74 |
| 52-week low 3 | 18.11 |
| 50-day moving average 3 | 43.32 |
| 200-day moving average 3 | 33.70 |
Share statistics
| Avg vol (3-month) 3 | 710.51k |
| Avg vol (10-day) 3 | 658.82k |
| Shares outstanding 5 | 74.76M |
| Implied shares outstanding 6 | 77.15M |
| Float 8 | 73.78M |
| % held by insiders 1 | 0.98% |
| % held by institutions 1 | 102.67% |
| Shares short (15 Apr 2024) 4 | 9.83M |
| Short ratio (15 Apr 2024) 4 | 14.7 |
| Short % of float (15 Apr 2024) 4 | 14.92% |
| Short % of shares outstanding (15 Apr 2024) 4 | 13.15% |
| Shares short (prior month 15 Mar 2024) 4 | 8.82M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -1,068.77% |
Management effectiveness
| Return on assets (ttm) | -16.20% |
| Return on equity (ttm) | -23.28% |
Income statement
| Revenue (ttm) | 23.39M |
| Revenue per share (ttm) | 0.41 |
| Quarterly revenue growth (yoy) | -2.50% |
| Gross profit (ttm) | N/A |
| EBITDA | -131.95M |
| Net income avi to common (ttm) | -112.96M |
| Diluted EPS (ttm) | -1.96 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 525.11M |
| Total cash per share (mrq) | 7.04 |
| Total debt (mrq) | 2.87M |
| Total debt/equity (mrq) | 0.46% |
| Current ratio (mrq) | 19.65 |
| Book value per share (mrq) | 9.55 |
Cash flow statement
| Operating cash flow (ttm) | -115.22M |
| Levered free cash flow (ttm) | -70.28M |
© 2024 Yahoo. All rights reserved.